Literature DB >> 10614602

Hospital characteristics associated with colonization of water systems by Legionella and risk of nosocomial legionnaires' disease: a cohort study of 15 hospitals.

J L Kool1, D Bergmire-Sweat, J C Butler, E W Brown, D J Peabody, D S Massi, J C Carpenter, J M Pruckler, R F Benson, B S Fields.   

Abstract

OBJECTIVE: To investigate an increase in reports of legionnaires' disease by multiple hospitals in San Antonio, Texas, and to study risk factors for nosocomial transmission of legionnaires' disease and determinants for Legionella colonization of hospital hot-water systems.
SETTING: The 16 largest hospitals in the cities of San Antonio, Temple, and Austin, Texas.
DESIGN: Review of laboratory databases to identify patients with legionnaires' disease in the 3 years prior to the investigation and to determine the number of diagnostic tests for Legionella performed; measurement of hot-water temperature and chlorine concentration and culture of potable water for Legionella. Exact univariate calculations, Poisson regression, and linear regression were used to determine factors associated with water-system colonization and transmission of Legionella.
RESULTS: Twelve cases of nosocomial legionnaires' disease were identified; eight of these occurred in 1996. The rise in cases occurred shortly after physicians started requesting Legionella urinary antigen tests. Hospitals that frequently used Legionella urinary antigen tests tended to detect more cases of legionnaires' disease. Legionella was isolated from the water systems of 11 of 12 hospitals in San Antonio; the 12th had just experienced an outbreak of legionnaires' disease and had implemented control measures. Nosocomial legionellosis cases probably occurred in 5 hospitals. The number of nosocomial legionnaires' disease cases in each hospital correlated better with the proportion of water-system sites that tested positive for Legionella (P=.07) than with the concentration of Legionella bacteria in water samples (P=.23). Hospitals in municipalities where the water treatment plant used monochloramine as a residual disinfectant (n=4) and the hospital that had implemented control measures were Legionella-free. The hot-water systems of all other hospitals (n=11) were colonized with Legionella. These were all supplied with municipal drinking water that contained free chlorine as a residual disinfectant. In these contaminated hospitals, the proportion of sites testing positive was inversely correlated with free residual chlorine concentration (P=.01). In all hospitals, hot-water temperatures were too low to inhibit Legionella growth.
CONCLUSIONS: The increase in reporting of nosocomial legionnaires' disease was attributable to increased use of urinary antigen tests; prior cases may have gone unrecognized. Risk of legionnaires' disease in hospital patients was better predicted by the proportion of water-system sites testing positive for Legionella than by the measured concentration of Legionella bacteria. Use of monochloramine by municipalities for residual drinking water disinfection may help prevent legionnaires' disease.

Entities:  

Mesh:

Year:  1999        PMID: 10614602     DOI: 10.1086/501587

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  30 in total

1.  Coping with Legionella.

Authors:  E Weir
Journal:  CMAJ       Date:  2000-11-14       Impact factor: 8.262

2.  Waterborne Nosocomial Infections.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-12       Impact factor: 3.725

3.  Legionella contamination in hot water of Italian hotels.

Authors:  Paola Borella; Maria Teresa Montagna; Serena Stampi; Giovanna Stancanelli; Vincenzo Romano-Spica; Maria Triassi; Isabella Marchesi; Annalisa Bargellini; Daniela Tatò; Christian Napoli; Franca Zanetti; Erica Leoni; Matteo Moro; Stefania Scaltriti; Gabriella Ribera D'Alcalà; Rosalba Santarpia; Stefania Boccia
Journal:  Appl Environ Microbiol       Date:  2005-10       Impact factor: 4.792

4.  Integrated real-time PCR for detection and monitoring of Legionella pneumophila in water systems.

Authors:  Diaraf Farba Yaradou; Sylvie Hallier-Soulier; Sophie Moreau; Florence Poty; Yves Hillion; Monique Reyrolle; Janine André; Gabriel Festoc; Karine Delabre; François Vandenesch; Jerome Etienne; Sophie Jarraud
Journal:  Appl Environ Microbiol       Date:  2006-12-28       Impact factor: 4.792

5.  Detection of legionellae in hospital water samples by quantitative real-time LightCycler PCR.

Authors:  N Wellinghausen; C Frost; R Marre
Journal:  Appl Environ Microbiol       Date:  2001-09       Impact factor: 4.792

6.  Quantitative real-time Legionella PCR for environmental water samples: data interpretation.

Authors:  Philippe Joly; Pierre-Alain Falconnet; Janine André; Nicole Weill; Monique Reyrolle; François Vandenesch; Max Maurin; Jerome Etienne; Sophie Jarraud
Journal:  Appl Environ Microbiol       Date:  2006-04       Impact factor: 4.792

7.  Rapid detection and enumeration of Legionella pneumophila in hot water systems by solid-phase cytometry.

Authors:  Helena Aurell; Philippe Catala; Pierre Farge; France Wallet; Matthieu Le Brun; Jürgen H Helbig; Sophie Jarraud; Philippe Lebaron
Journal:  Appl Environ Microbiol       Date:  2004-03       Impact factor: 4.792

Review 8.  Legionella and Legionnaires' disease: 25 years of investigation.

Authors:  Barry S Fields; Robert F Benson; Richard E Besser
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

9.  Direct detection and differentiation of Legionella spp. and Legionella pneumophila in clinical specimens by dual-color real-time PCR and melting curve analysis.

Authors:  Udo Reischl; Hans-Jörg Linde; Norbert Lehn; Olfert Landt; Kevin Barratt; Nele Wellinghausen
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948

10.  Noninvasive ventilation for patients near the end of life: what do we know and what do we need to know?

Authors:  William J Ehlenbach; J Randall Curtis
Journal:  Crit Care Med       Date:  2008-03       Impact factor: 7.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.